IBDEI2ZV ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47818,1,3,0)
 ;;=3^Lupus Erythematosus,Subacute Cutaneous
 ;;^UTILITY(U,$J,358.3,47818,1,4,0)
 ;;=4^L93.1
 ;;^UTILITY(U,$J,358.3,47818,2)
 ;;=^5009468
 ;;^UTILITY(U,$J,358.3,47819,0)
 ;;=L93.2^^185^2412^54
 ;;^UTILITY(U,$J,358.3,47819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47819,1,3,0)
 ;;=3^Lupus Erythematosus,Other
 ;;^UTILITY(U,$J,358.3,47819,1,4,0)
 ;;=4^L93.2
 ;;^UTILITY(U,$J,358.3,47819,2)
 ;;=^5009469
 ;;^UTILITY(U,$J,358.3,47820,0)
 ;;=L04.9^^185^2412^59
 ;;^UTILITY(U,$J,358.3,47820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47820,1,3,0)
 ;;=3^Lymphadenitis,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,47820,1,4,0)
 ;;=4^L04.9
 ;;^UTILITY(U,$J,358.3,47820,2)
 ;;=^5009074
 ;;^UTILITY(U,$J,358.3,47821,0)
 ;;=R59.1^^185^2412^56
 ;;^UTILITY(U,$J,358.3,47821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47821,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Generalized
 ;;^UTILITY(U,$J,358.3,47821,1,4,0)
 ;;=4^R59.1
 ;;^UTILITY(U,$J,358.3,47821,2)
 ;;=^5019530
 ;;^UTILITY(U,$J,358.3,47822,0)
 ;;=R59.0^^185^2412^57
 ;;^UTILITY(U,$J,358.3,47822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47822,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Localized
 ;;^UTILITY(U,$J,358.3,47822,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,47822,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,47823,0)
 ;;=R59.9^^185^2412^58
 ;;^UTILITY(U,$J,358.3,47823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47823,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Unspec
 ;;^UTILITY(U,$J,358.3,47823,1,4,0)
 ;;=4^R59.9
 ;;^UTILITY(U,$J,358.3,47823,2)
 ;;=^5019531
 ;;^UTILITY(U,$J,358.3,47824,0)
 ;;=L60.9^^185^2412^61
 ;;^UTILITY(U,$J,358.3,47824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47824,1,3,0)
 ;;=3^Nail Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,47824,1,4,0)
 ;;=4^L60.9
 ;;^UTILITY(U,$J,358.3,47824,2)
 ;;=^5009240
 ;;^UTILITY(U,$J,358.3,47825,0)
 ;;=L60.3^^185^2412^62
 ;;^UTILITY(U,$J,358.3,47825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47825,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,47825,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,47825,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,47826,0)
 ;;=L60.0^^185^2412^63
 ;;^UTILITY(U,$J,358.3,47826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47826,1,3,0)
 ;;=3^Nail,Ingrowing
 ;;^UTILITY(U,$J,358.3,47826,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,47826,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,47827,0)
 ;;=L60.2^^185^2412^70
 ;;^UTILITY(U,$J,358.3,47827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47827,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,47827,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,47827,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,47828,0)
 ;;=L97.109^^185^2412^69
 ;;^UTILITY(U,$J,358.3,47828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47828,1,3,0)
 ;;=3^Nonpressure Chr Ulcer of Thigh
 ;;^UTILITY(U,$J,358.3,47828,1,4,0)
 ;;=4^L97.109
 ;;^UTILITY(U,$J,358.3,47828,2)
 ;;=^5009484
 ;;^UTILITY(U,$J,358.3,47829,0)
 ;;=L97.209^^185^2412^65
 ;;^UTILITY(U,$J,358.3,47829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47829,1,3,0)
 ;;=3^Nonpressure Chr Ulcer of Calf
 ;;^UTILITY(U,$J,358.3,47829,1,4,0)
 ;;=4^L97.209
 ;;^UTILITY(U,$J,358.3,47829,2)
 ;;=^5009499
 ;;^UTILITY(U,$J,358.3,47830,0)
 ;;=L97.309^^185^2412^64
 ;;^UTILITY(U,$J,358.3,47830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47830,1,3,0)
 ;;=3^Nonpressure Chr Ulcer of Ankle
 ;;^UTILITY(U,$J,358.3,47830,1,4,0)
 ;;=4^L97.309
